Clients value Greg’s strategic counsel relating to the protection of their intellectual property assets in the U.S. and abroad. His outstanding track record is built on successful outcomes in high-profile and high-value life sciences and chemical patent matters.

Greg’s extensive background encompasses patent preparation and prosecution, enforcement, and technology dispute resolution, as well as licensing and opinion work in the following technical areas:

• Therapeutics and small molecules, including orphan disease treatment

• Diagnostics

• Specialty chemicals and polymers

• Material science

• Medical devices